MENU
CRSP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
CRISPR Therapeutics AG (CRSP) Ownership - Who owns CRISPR Therapeutics AG?
Crispr Therapeutics AG is a gene editing company focused on the development of Crispr/Cas9-based therapeutics... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
Baarerstrasse 14
Phone
+41 415613277
Employees
407
Web
https://www.crisprtx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.31B
P/E Ratio
N/A
Total Cash
1.9B
Projected Growth
N/A
Total Debt
223.69M
Revenue
35M
Risk (Beta)
1.90
Dividend Yield
N/A
Total Cash/Share
22.04
Total Debt/Equity
N/A
Revenue/Share
0.41 USD as % of share price
Fundamentals
CRSP
Capitalization
3.31B
P/E Ratio
N/A
Risk (Beta)
1.90
Dividend Yield
N/A
Total Cash
1.9B
Total Cash/Share
22.04
Total Debt
224M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.41%
Revenue
35M
ROE
N/A
Book Value
1.93B
P/B Ratio
1.71
Cash Flow
N/A
Earnings
-4.34
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.7M
Current Ratio
22.07
Current Revenue Per Employee
89058.52
Dividends Per Share - Security
N/A
EBITDA
-447.31M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-16.38
Shares Held By Institutions
9.28B
Shares Outstanding - Current
86.4M
Total Liabilities
310M
Total Volume MTD
N/A
Value
-1
Gain YTD
-2.769
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of gene-based medicines
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
Baarerstrasse 14
Phone
+41 415613277
Employees
407
Web
https://www.crisprtx.com